Immunogenicity and crossreactivity of antibodies to SARS-CoV-2 nucleocapsid protein
View ORCID ProfileCarlota Dobaño, Rebeca Santano, Alfons Jiménez, Marta Vidal, Jordi Chi, Natalia Rodrigo Melero, Matija Popovic, Rubén López-Aladid, Laia Fernández-Barat, Marta Tortajada, Francisco Carmona-Torre, Gabriel Reina, Antoni Torres, Alfredo Mayor, Carlo Carolis, Alberto L. García-Basteiro, Ruth Aguilar, Gemma Moncunill, Luis Izquierdo
doi: https://doi.org/10.1101/2020.12.19.20248551
Carlota Dobaño
1ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Catalonia, Spain
2Spanish Consortium for Research in Epidemiology and Public Health (CIBERESP), Spain
Rebeca Santano
1ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Catalonia, Spain
Alfons Jiménez
1ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Catalonia, Spain
2Spanish Consortium for Research in Epidemiology and Public Health (CIBERESP), Spain
Marta Vidal
1ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Catalonia, Spain
Jordi Chi
1ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Catalonia, Spain
Natalia Rodrigo Melero
3Biomolecular screening and Protein Technologies Unit, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain
Matija Popovic
3Biomolecular screening and Protein Technologies Unit, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain
Rubén López-Aladid
4Cellex Laboratory, CibeRes (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, 06/06/0028), Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic, Barcelona, Spain
Laia Fernández-Barat
4Cellex Laboratory, CibeRes (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, 06/06/0028), Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic, Barcelona, Spain
Marta Tortajada
5Occupational Health Department, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain
Francisco Carmona-Torre
6Infectious Diseases Division and Clinical Microbiology, Clínica Universidad de Navarra, Pamplona, Spain
7IdiSNA, Navarra Institute for Health Research, Spain
Gabriel Reina
8Clínica Universidad de Navarra, Navarra Institute for Health Research, Pamplona, Spain
Antoni Torres
4Cellex Laboratory, CibeRes (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, 06/06/0028), Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic, Barcelona, Spain
9Pneumology Service, Hospital Clinic, Barcelona, Spain
Alfredo Mayor
1ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Catalonia, Spain
2Spanish Consortium for Research in Epidemiology and Public Health (CIBERESP), Spain
10Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique
Carlo Carolis
3Biomolecular screening and Protein Technologies Unit, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain
Alberto L. García-Basteiro
1ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Catalonia, Spain
10Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique
11International Health Department, Hospital Clinic, Universitat de Barcelona, Spain
Ruth Aguilar
1ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Catalonia, Spain
Gemma Moncunill
1ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Catalonia, Spain
Luis Izquierdo
1ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Catalonia, Spain
Posted December 22, 2020.
Immunogenicity and crossreactivity of antibodies to SARS-CoV-2 nucleocapsid protein
Carlota Dobaño, Rebeca Santano, Alfons Jiménez, Marta Vidal, Jordi Chi, Natalia Rodrigo Melero, Matija Popovic, Rubén López-Aladid, Laia Fernández-Barat, Marta Tortajada, Francisco Carmona-Torre, Gabriel Reina, Antoni Torres, Alfredo Mayor, Carlo Carolis, Alberto L. García-Basteiro, Ruth Aguilar, Gemma Moncunill, Luis Izquierdo
medRxiv 2020.12.19.20248551; doi: https://doi.org/10.1101/2020.12.19.20248551
Immunogenicity and crossreactivity of antibodies to SARS-CoV-2 nucleocapsid protein
Carlota Dobaño, Rebeca Santano, Alfons Jiménez, Marta Vidal, Jordi Chi, Natalia Rodrigo Melero, Matija Popovic, Rubén López-Aladid, Laia Fernández-Barat, Marta Tortajada, Francisco Carmona-Torre, Gabriel Reina, Antoni Torres, Alfredo Mayor, Carlo Carolis, Alberto L. García-Basteiro, Ruth Aguilar, Gemma Moncunill, Luis Izquierdo
medRxiv 2020.12.19.20248551; doi: https://doi.org/10.1101/2020.12.19.20248551
Subject Area
Subject Areas
- Addiction Medicine (350)
- Allergy and Immunology (674)
- Anesthesia (181)
- Cardiovascular Medicine (2666)
- Dermatology (225)
- Emergency Medicine (404)
- Epidemiology (12278)
- Forensic Medicine (10)
- Gastroenterology (766)
- Genetic and Genomic Medicine (4132)
- Geriatric Medicine (387)
- Health Economics (682)
- Health Informatics (2677)
- Health Policy (1008)
- Hematology (364)
- HIV/AIDS (855)
- Medical Education (400)
- Medical Ethics (109)
- Nephrology (443)
- Neurology (3920)
- Nursing (212)
- Nutrition (583)
- Oncology (2056)
- Ophthalmology (591)
- Orthopedics (242)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1121)
- Primary Care Research (458)
- Public and Global Health (6556)
- Radiology and Imaging (1411)
- Respiratory Medicine (874)
- Rheumatology (413)
- Sports Medicine (344)
- Surgery (453)
- Toxicology (54)
- Transplantation (187)
- Urology (167)